Beactica is a specialized drug research company that uses its proprietary methods to evaluate the interaction between molecules to generate new therapies.
Today, Beactica is considered by its employees and partners to be a leader in fragment-based drug development using SPR biosensor technology. This position has its roots in a unique heritage that spans decades of research and industrial development.
